Takeaway
Among patients with neuromuscular diseases (NMDs), demographic and clinical characteristics confer differential risk of severe COVID-19 outcomes.
Why this matters
There is a paucity of data regarding the risk and outcomes of COVID-19 in patients with NMDs.
Understanding the risk factors associated with severe COVID-19 in these patients can aid in identifying and optimizing management of vulnerable patient populations.